IRIS Accounts Production v25.4.0.155 11263627 Board of Directors 1.4.24 31.3.25 31.3.25 31/12/2025 0 0 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh112636272024-03-31112636272025-03-31112636272024-04-012025-03-31112636272023-03-31112636272023-04-012024-03-31112636272024-03-3111263627ns15:EnglandWales2024-04-012025-03-3111263627ns14:PoundSterling2024-04-012025-03-3111263627ns10:Director12024-04-012025-03-3111263627ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3111263627ns10:SmallEntities2024-04-012025-03-3111263627ns10:Audited2024-04-012025-03-3111263627ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3111263627ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3111263627ns10:FullAccounts2024-04-012025-03-3111263627ns10:OrdinaryShareClass12024-04-012025-03-3111263627ns10:Director22024-04-012025-03-3111263627ns10:Director32024-04-012025-03-3111263627ns10:Director42024-04-012025-03-3111263627ns10:RegisteredOffice2024-04-012025-03-3111263627ns5:CurrentFinancialInstruments2025-03-3111263627ns5:CurrentFinancialInstruments2024-03-3111263627ns5:ShareCapital2025-03-3111263627ns5:ShareCapital2024-03-3111263627ns5:RetainedEarningsAccumulatedLosses2025-03-3111263627ns5:PlantMachinery2024-03-3111263627ns5:PlantMachinery2024-04-012025-03-3111263627ns5:PlantMachinery2025-03-3111263627ns5:PlantMachinery2024-03-3111263627ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3111263627ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3111263627ns5:WithinOneYear2025-03-3111263627ns5:WithinOneYear2024-03-3111263627ns5:BetweenOneFiveYears2025-03-3111263627ns5:BetweenOneFiveYears2024-03-3111263627ns5:AllPeriods2025-03-3111263627ns5:AllPeriods2024-03-3111263627ns10:OrdinaryShareClass12025-03-3111263627ns5:PreviouslyStatedAmountns5:RetainedEarningsAccumulatedLosses2024-03-3111263627ns5:PriorPeriodIncreaseDecreasens5:RetainedEarningsAccumulatedLosses2024-04-012025-03-3111263627ns5:RetainedEarningsAccumulatedLosses2024-03-3111263627ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-31
REGISTERED NUMBER: 11263627 (England and Wales)











FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

INSPIRE MEDICARE LTD.

INSPIRE MEDICARE LTD. (REGISTERED NUMBER: 11263627)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


INSPIRE MEDICARE LTD.

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: R S Bhamra
V K Khanna
M V Lloyd
H N Miller





REGISTERED OFFICE: 130-136 Maidstone Road
Sidcup
Kent
DA14 5HS





REGISTERED NUMBER: 11263627 (England and Wales)





AUDITORS: Sargeant Partnership Limited
Chartered Accountants
and Statutory Auditors
5 White Oak Square
London Road
Swanley
Kent
BR8 7AG

INSPIRE MEDICARE LTD. (REGISTERED NUMBER: 11263627)

BALANCE SHEET
31 MARCH 2025

2025 2024
as restated
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,567 2,795

CURRENT ASSETS
Stocks 47,457 92,493
Debtors 5 2,245,354 1,704,462
Cash at bank 83,814 99,860
2,376,625 1,896,815
CREDITORS
Amounts falling due within one year 6 2,246,135 1,776,898
NET CURRENT ASSETS 130,490 119,917
TOTAL ASSETS LESS CURRENT
LIABILITIES

133,057

122,712

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 9 132,957 122,612
SHAREHOLDERS' FUNDS 133,057 122,712

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 December 2025 and were signed on its behalf by:





V K Khanna - Director


INSPIRE MEDICARE LTD. (REGISTERED NUMBER: 11263627)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

Inspire Medicare Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

- Section 7 'Statement of Cash Flows': Presentation of a statement of cash flow and related notes and disclosures;

- Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

- Section 26 'Share based Payment': Share-based payment expense charged to profit or loss, reconciliation of opening and closing number and weighted average exercise price of share options, how the fair value of options granted was measured, measurement and carrying amount of liabilities for cash-settled share-based payments, explanation of modifications to arrangements;

- Section 33 'Related Party Disclosures': Compensation for key management personnel.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

INSPIRE MEDICARE LTD. (REGISTERED NUMBER: 11263627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Assets costing £500 or more are capitalised as tangible fixed assets and are carried at cost, net of depreciation and any provision for impairment.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Rental assets 25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for any stock provision. If items in stock have not moved in the previous 24 months, a provision of 100% is then applied.

INSPIRE MEDICARE LTD. (REGISTERED NUMBER: 11263627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

INSPIRE MEDICARE LTD. (REGISTERED NUMBER: 11263627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

INSPIRE MEDICARE LTD. (REGISTERED NUMBER: 11263627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Cash at bank
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are within borrowings in current liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

INSPIRE MEDICARE LTD. (REGISTERED NUMBER: 11263627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

4. TANGIBLE FIXED ASSETS
Rental
£   
COST
At 1 April 2024 2,795
Additions 525
At 31 March 2025 3,320
DEPRECIATION
Charge for year 753
At 31 March 2025 753
NET BOOK VALUE
At 31 March 2025 2,567
At 31 March 2024 2,795

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
as restated
£    £   
Trade debtors 485,171 410,774
Amounts owed by group undertakings 1,678,261 1,188,902
Other debtors 81,922 104,786
2,245,354 1,704,462

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
as restated
£    £   
Trade creditors 118,750 96,183
Amounts owed to group undertakings 1,933,200 1,381,077
Tax 890 10,068
VAT 146,106 194,053
Other creditors - 6,695
Accruals and deferred income 12,156 12,167
Accrued expenses 35,033 76,655
2,246,135 1,776,898

INSPIRE MEDICARE LTD. (REGISTERED NUMBER: 11263627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2025 2024
as restated
£    £   
Within one year 1,481 1,306
Between one and five years 2,081 3,676
3,562 4,982

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: as restated
£    £   
100 Ordinary £1 100 100

9. RESERVES
Retained
earnings
£   

At 1 April 2024 99,723
Prior year adjustment 22,889
122,612
Profit for the year 10,345
At 31 March 2025 132,957

10. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Joanne Brown (Senior Statutory Auditor)
for and on behalf of Sargeant Partnership Limited

11. RELATED PARTY DISCLOSURES

Other than the directors the only other key management personnel is G Micallef.

12. ULTIMATE CONTROLLING PARTY

The company is a wholly owned subsidiary of Inspire Community Trust whose registered office is 130-136 Maidstone Road Sidcup Maidstone Road, Sidcup, England, DA14 5HS. Copies of the group accounts can be obtained from the registered office.